1. Trial watch: local anesthetics in cancer therapy
   Killian Carnet Le Provost et al, 2024, OncoImmunology CrossRef
2. Therapeutic Targeting of the Regulators of Cancer Epigenomes
   Ismail Al-Janabi, 2023, Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) CrossRef
3. Recent progress in DNA methyltransferase inhibitors as anticancer agents
   Zhixiong Zhang et al, 2022, Frontiers in Pharmacology CrossRef
4. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification
   Shan-Ju Yeh et al, 2019, Oncotarget CrossRef
5. Research progress and applications of epigenetic biomarkers in cancer
   Jianjun Gao et al, 2024, Frontiers in Pharmacology CrossRef
6. Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
   Filipa Moreira-Silva et al, 2020, Pharmaceutics CrossRef
7. Food for Bone: Evidence for a Role for Delta-Tocotrienol in the Physiological Control of Osteoblast Migration
   Lavinia Casati et al, 2020, International Journal of Molecular Sciences CrossRef
8. Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
   Michel Montalvo-Casimiro et al, 2020, Frontiers in Oncology CrossRef
9. Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer
   Alejandra Wu Chuang et al, 2022, Frontiers in Oncology CrossRef
10. Impact of local anesthetics on epigenetics in cancer
    Lucillia Bezu et al, 2022, Frontiers in Oncology CrossRef
11. Drug Repurposing for Epigenetic Targets Guided by Computational Methods
    J. Jesús Naveja et al, 2016, Epi-Informatics CrossRef
12. Procaine–The Controversial Geroprotector Candidate: New Insights Regarding Its Molecular and Cellular Effects
    Daniela Gradinaru et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef